Testagem inicial e capacidade discriminatória da escala "UFMG Sydenham's Chorea Rating Scale (USCRS)"

Translated title of the contribution: The initial testing and the discrimination property of the UFMG Sydenham's Chorea Rating Scale (USCRS)

Antônio Lúcio Teixeira, Débora Palma Maia, Francisco Cardoso

Research output: Contribution to journalArticlepeer-review

7 Scopus citations

Abstract

Recently we developed and validated the Universidade Federal de Minas Gerais (UFMG) Sydenham's chorea Rating Scale (USCRS) to systematically assess SC patients. In this study, we assessed 97 children and adults with SC (mean age ± SD, 15.5 ± 5.9; male/female, 31/66) seen at the Movement Disorders Clinic at UFMG employing the USCRS. The patients were divided into 4 groups according to their clinical status: acute (n=19), recurrent (n=17), persistent (n=19) and remission (n=42). The mean ± SEM USCRS scores for each group were: 47.7 ± 4.7 for acute group, 29.5 ± 2.6 for recurrent group, 17.6 ± 3.1 for persistent group and 1.1 ± 0.2 for remission group. All pair comparisons were statistically significant (p<0.05). Our results indicate that the USRSC can reasonably discriminate groups of SC patients in different clinical stages of the disease.

Translated title of the contributionThe initial testing and the discrimination property of the UFMG Sydenham's Chorea Rating Scale (USCRS)
Original languagePortuguese
Pages (from-to)825-827
Number of pages3
JournalArquivos de neuro-psiquiatria
Volume63
Issue number3 B
DOIs
StatePublished - Sep 2005
Externally publishedYes

Keywords

  • Rating scale
  • Sydenham's chorea

ASJC Scopus subject areas

  • Clinical Neurology
  • Biological Psychiatry

Fingerprint

Dive into the research topics of 'The initial testing and the discrimination property of the UFMG Sydenham's Chorea Rating Scale (USCRS)'. Together they form a unique fingerprint.

Cite this